FDA Authorizes Altria's Copenhagen Snuff for Modified-Risk Marketing
March 16 2023 - 12:17PM
Dow Jones News
By Will Feuer
The Food and Drug Administration authorized Altria Group
Inc.-owned U.S. Smokeless Tobacco Co.'s Copenhagen Classic Snuff
product to be marketed as a modified-risk tobacco product, or
MRTP.
The authorization means that the product, which is a smokeless
tobacco product, can be marketed with the language: "IF YOU SMOKE,
CONSIDER THIS: Switching completely to this product from cigarettes
reduces risk of lung cancer."
The FDA said its staff reviewed available evidence, public
comments and recommendations from expert committees and concluded
that the claim in the language is accurate.
The company is still required to conduct postmarket
surveillance. The modified-risk granted order will expire in five
years and the company will need to receive authorization then to
continue to market the product as a MRTP, the FDA said.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
March 16, 2023 12:02 ET (16:02 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Altria (NYSE:MO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Altria (NYSE:MO)
Historical Stock Chart
From Apr 2023 to Apr 2024
